Dyne Therapeutics reported earnings of -$ 1.06 per DYN share on Nov 5, 2026, beating analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 0.91 |
| Earnings Per Share (Surprise) | -$ 1.06 (-$ 0.15) |
| Last Year's EPS | -$ 0.89 |
| EPS YoY Change |
Out of the last 73 earnings reporting periods, Dyne Therapeutics beat analysts’ expectations 9 times and fell short of expectations 15 time(s). Dyne Therapeutics reported earnings per share of -$ 1.06 in the last report falling to reach an estimated EPS of -$ 0.91 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.91 | -$ 1.06 | -$ 0.76 | |
| Jul 30, 2026 | -$ 0.75 | -$ 1.08 | -$ 0.97 | |
| May 11, 2026 | -$ 0.77 | -$ 0.73 | -$ 1.05 | |
| Mar 2, 2026 | -$ 0.74 | -$ 0.76 | -$ 0.88 | |
| Nov 5, 2025 | -$ 0.81 | -$ 0.76 | -$ 0.96 | |
| Jul 28, 2025 | -$ 0.99 | -$ 0.97 | -$ 0.70 | |
| May 8, 2025 | -$ 0.88 | -$ 1.05 | -$ 0.81 | |
| Feb 27, 2025 | -$ 0.92 | -$ 0.88 | -$ 1.09 | |
| Nov 12, 2024 | -$ 0.71 | -$ 0.96 | -$ 0.99 | |
| Aug 12, 2024 | -$ 0.72 | -$ 0.70 | -$ 1.08 | |
| May 2, 2024 | -$ 0.81 | -$ 0.81 | -$ 0.78 | |
| Mar 5, 2024 | -$ 0.92 | -$ 1.09 | -$ 0.74 | |
| Oct 30, 2023 | -$ 0.86 | -$ 0.99 | -$ 0.80 | |
| Aug 3, 2023 | -$ 0.81 | -$ 1.08 | -$ 1.01 | |
| May 11, 2023 | -$ 0.77 | -$ 0.78 | -$ 0.69 | |
| Mar 2, 2023 | -$ 0.84 | -$ 0.74 | -$ 1.00 | |
| Nov 3, 2022 | -$ 0.95 | -$ 0.80 | -$ 0.83 | |
| Aug 4, 2022 | -$ 0.79 | -$ 1.01 | -$ 0.58 | |
| May 2, 2022 | -$ 0.88 | -$ 0.69 | -$ 0.50 | |
| Mar 10, 2022 | -$ 0.99 | -$ 1.00 | -$ 0.64 |
Dyne Therapeutics’s stock was trading at $ 18.54 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, DYN’s price decreased to $ 18.07 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 1.06 | $ 18.54 | $ 18.07 | |
| Jul 30, 2026 | -$ 1.08 | $ 25.10 | $ 25.18 | |
| May 11, 2026 | -$ 0.73 | $ 17.61 | $ 18.37 | |
| Mar 2, 2026 | -$ 0.76 | $ 15.62 | $ 14.60 | |
| Nov 5, 2025 | -$ 0.76 | $ 21.52 | $ 18.20 | |
| Jul 28, 2025 | -$ 0.97 | $ 9.95 | $ 9.20 | |
| May 8, 2025 | -$ 1.05 | $ 9.40 | $ 11.41 | |
| Feb 27, 2025 | -$ 0.88 | $ 13.79 | $ 13.61 | |
| Nov 12, 2024 | -$ 0.96 | $ 28.13 | $ 34.13 | |
| Aug 12, 2024 | -$ 0.70 | $ 43.60 | $ 43.64 | |
| May 2, 2024 | -$ 0.81 | $ 25.83 | $ 26.08 | |
| Mar 5, 2024 | -$ 1.09 | $ 27.71 | $ 26.78 | |
| Oct 30, 2023 | -$ 0.99 | $ 6.62 | $ 7.05 | |
| Aug 3, 2023 | -$ 1.08 | $ 11.76 | $ 11.55 | |
| May 11, 2023 | -$ 0.78 | $ 14.00 | $ 13.43 | |
| Mar 2, 2023 | -$ 0.74 | $ 13.63 | $ 15.00 | |
| Nov 3, 2022 | -$ 0.80 | $ 10.28 | $ 10.44 | |
| Aug 4, 2022 | -$ 1.01 | $ 10.97 | $ 11.44 | |
| May 2, 2022 | -$ 0.69 | $ 7.98 | $ 8.82 | |
| Mar 10, 2022 | -$ 1.00 | $ 8.89 | $ 8.74 |
Dyne Therapeutics released its most recent earnings reports in November 2026, July 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Dyne Therapeutics missed analysts’ expectations during the last earnings period by
